Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality hip

Clinical Orthopaedics and Related Research

Volumn 471, Issue 2, 2013, Pages 510-518

  Berend, Keith R ^a,b,c   Lombardi Jr , Adolph V ^a,b,c,d   Morris, Michael J ^a,c   Bergeson, Adam G ^a,c   Adams, Joanne B ^a   Sneller, Michael A ^a  

^a Joint Implant Surgeons Inc   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MOUNT CARMEL HEALTH SYSTEM   (United States)

^d Ohio State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; C REACTIVE PROTEIN; CEPHALOSPORIN; GENTAMICIN; ANTIINFECTIVE AGENT;

ADULT; AGED; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEBRIDEMENT; DEVICE REMOVAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FOREIGN BODY; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PATIENT SELECTION; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; PSEUDOMONAS; REIMPLANTATION; REINFECTION RATE; STAPHYLOCOCCUS; STREPTOCOCCUS; SURGICAL MORTALITY; TOTAL HIP PROSTHESIS; WOUND HEALING; ARTICLE; HIP; HIP ARTHROPLASTY; HIP PROSTHESIS; INFECTION; MIDDLE AGED; MORTALITY; REOPERATION; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BONE CEMENTS; DEBRIDEMENT; FEMALE; HIP JOINT; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; REOPERATION; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84878216745     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2595-x     Document Type: Conference Paper

References (37)

1. Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. J Bone Joint Surg Br. 2005;87:314-319. (Pubitemid 40424856)
2. Cabrita HB, Croci AT, de Camargo OP, de Lima ALLM. Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic-loaded cement spacer. Clinics (Sao Paulo). 2007;62:99-108.
3. Cordero-Ampuero J, Esteban J, Garcia-Cimbrelo E. Oral antibiotics are effective for highly resistant hip arthroplasty infections. Clin Orthop Relat Res. 2009;467:2335-2342.
4. Evans RP. Successful treatment of total hip and knee infection with articulating antibiotic components. Clin Orthop Relat Res. 2004;427:37-46. (Pubitemid 39362828)
5. Fehring TK, Calton TF, Griffin WL. Cementless fixation in 2-stage reimplantation for periprosthetic sepsis. J Arthroplasty. 1999;14:175-181. (Pubitemid 29095960)
6. Fink B, Grossmann A, Fuerst M, Schafer P, Fromelt L. Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res. 2009;467:1848-1858.
7. Garvin KL, Hanssen AD. Infection after total hip arthroplasty: past, present, and future. J Bone Joint Surg Am. 1995;77:1576-1588.
8. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737-755.
9. Hofmann AA, Goldberg TD, Tanner AM, Cook TM. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty. 2005;20:874-879. (Pubitemid 41463687)
10. Incavo SJ, Russell RD, Mathis KB, Adams H. Initial results of managing severe bone loss in infected total joint arthroplasty using customized articulating spacers. J Arthroplasty. 2009;24:607-613.
11. Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2001;83:1622-1629.
12. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res. 2010;96:124-132.
13. Koo K-H, Yang J-W, Cho S-H, Song H-R, Park H-B, Ha Y-C, Chang J-D, Kim S-Y, Kim Y-H. Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty. 2001;16:882-892. (Pubitemid 32971600)
14. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984-991.
15. Lange J, Troelsen A, Thomsen RW, Soballe K. Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis. Clin Epidemiol. 2012;4:57-73.
16. Lee PTH, Clayton RA, Safir OA, Backstein DJ, Gross AE. Structural allograft as an option for treating infected hip arthroplasty with massive bone loss. Clin Orthop Relat Res. 2011;469:1016-1023.
17. Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res. 2011;469:1009-1015.
18. Lieberman JR, Callaway GH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994;301:205-212. (Pubitemid 24119275)
19. Lim S-J, Park J-C, Moon Y-W, Park Y-S. Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol. J Arthroplasty. 2009;24:1264-1269.
20. Magnan B, Regis D, Biscaglia R, Barolozzi P. Preformed acrylic bone cement spacer loaded with antibiotics. Acta Orthop Scand. 2001;72:591-594. (Pubitemid 34031655)
21. McDonald DJ, Fitzgerald RH, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am. 1989;71:828-834. (Pubitemid 19205262)
22. Nestor BJ, Hanssen AD, Ferrer-Gonzalez R, Fitzgerald RH. The use of porous prosthesis in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg Am. 1994;76:349-359. (Pubitemid 24138928)
23. Nusem J, Morgan DAF. Structural allografts for bone stock reconstruction in two-stage revision for infected total hip arthroplasty. Acta Orthop. 2006;77:92-97. (Pubitemid 43879159)
24. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710-1715.
25. Romano CL, Romano D, Logoluso N, Meani E. Long-stem versus short-stem preformed antibiotic-loaded cement spacers for two stage revision of infected total hip arthroplasty. Hip Int. 2010;20:26-33.
26. Sanchez-Sotelo J, Berry DJ, Hanssen AD, Cabanela ME. Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop Relat Res. 2009;467:219-224.
27. Scharfenberger A, Clark M, Lavoie G, O'Connor G, Masson E, Beaupre LA. Treatment of an infected total hip replacement with the PROSTALAC system. Part 1: infection resolution. Can J Surg. 2007;50:24-28.
28. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90:145-148. (Pubitemid 351303337)
29. Takigami I, Yoshiki I, Ishimaru D, Ogawa H, Mori N, Shimizu T, Terabayashi N, Shimizu K. Two-stage revision surgery for hip prosthesis infection using antibiotic-loaded porous hydroxyapatite blocks. Arch Orthop Trauma Surg. 2010;130:1221-1226.
30. Toulson C, Walcott-Sapp S, Hur J, Salvati EA, Bostrum M, Brause BD, Westrich GH. Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol. J Arthroplasty. 2009;24:1051-1060.
31. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. J Bone Joint Surg Am. 1996;78:512-523.
32. Wang J-W, Chen C-E. Reimplantation of infected hip arthroplasties using bone allografts. Clin Orthop Relat Res. 1997;335:202-210. (Pubitemid 27074497)
33. Whittaker JP, Warren RE, Jones RS, Gregson PA. Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br. 2009;91:44-51.
34. Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection. J Bone Joint Surg Am. 2011;93:631-639.
35. Yamamoto K, Miyagawa N, Masaoka T, Katori Y, Shishido T, Imakiire A. Clinical effectiveness of antibiotic-impregnated cement spacers for the treatment of infected implants of the hip joint. J Orthop Sci. 2003;8:823-828. (Pubitemid 38017671)
36. Younger ASE, Duncan CP, Masri BA, McGraw RW. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty. 1997;12:615-623. (Pubitemid 27427939)
37. Zhan C, Kaczmarek R, Loyo-Berrios N, Sangl J, Bright RA. Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg Am. 2007;89:526-533. (Pubitemid 46365352)